Containment Gene Expression Immune Response Protein 
XTalks
NOVEMBER 6, 2020
Symvivo’s bacTRL Gene Therapy Platform is designed and optimized to address limitations associated with typical vaccines, including the inability to accommodate large or multiple genes, lack of specificity to targeted tissue and poor control over immune response, says the company.
Drug Discovery World
DECEMBER 15, 2022
Potential solutions: For CRISPR systems, the likelihood of off-target editing has been shown to be influenced by a variety of factors, ranging from the design of the gRNA 1 and Cas9 protein 2 , to the targeted cell type 3 , to name a few examples. Notably, Scott and Zhang found ample targets for consideration in most genomic regions.
Expert insights. Personalized for you.
75 
Let's personalize your content